WELCOME TO HEP DART 2023
Hacienda del mar, Los Cabos, Mexico / 3-7 December 2023
We are pleased to announce Hep DART 2023 will be held at the Hacienda Del Mar from December 3-7, 2023 in Cabo San Lucas, Mexico.
After the conference in 2021 we sent a survey out to the former participants of Hep DART to assess were the delegates would like to hold the conference. We received an overwhelming response to continue to hold the conference in Cabo San Lucas. Cabo is an ideal location to hold a conference in December. The climate is warm with little chance of rain during that time of the year. This allows us to hold many events outdoors and provide ample space for social distancing. Additionally, the Cabo is a centralized location for international delegates while allowing additional visa access.
The DART series is and in-person meeting designed for vibrant scientific presentations and discussion, as well as for new investigators to meet leaders in their field, benefiting from educational feedback on their work.
The aim of HEP DART 2023 is to assemble clinicians, researchers, basic scientists, nurses and physician assistants together to advance our knowledge of the ongoing drug development processes in the treatment of viral hepatitis (HBV, HCV, HDV, HAV and HEV), non-alcoholic steatohepatitis (NASH), fibrosis, and hepatocellular carcinoma (HCC). This CME-accredited workshop will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community with an increased understanding of the current and future challenges in therapeutics for liver infection, disease and cancer.
We hope to see you in December!
History of HEP DART: Frontiers in Drug Development for Hepatology
Since its inception in 1995, HEP DART has provided a cutting-edge platform for tackling challenges in drug development for viral hepatitis and chronic liver disease. Hep DART has been held in-person every other year at various locations. HEP DART assembles clinicians, researchers, basic scientists, nurses and physician assistants together to advance our knowledge of the ongoing drug development processes in the treatment of viral hepatitis (HBV, HCV, HDV, HAV and HEV), non-alcoholic steatohepatitis (NASH), fibrosis, and hepatocellular carcinoma (HCC).
HEP DART 2023: Organizing Committee
Raymond F. Schinazi
Emory University, USA
Mark Sulkowski
Johns Hopkins University, USA
Manal El-Sayed
Ain Shams University, Egypt
Eugene Schiff
University of Miami, United States
Andrea Cox
Johns Hopkins Medicine United States
Charles Rice
Rockefeller University United States
Hep DAR2023: Scientific Committee
Harvey Alter, NIH, USA
Ralf Bartenschlager, University of Heidelberg, Germany
Mithat Bozdayi, Ankara University, Turkey
Carol Brosgart, University of California, San Francisco, USA
Francis Chisari, The Scripps Research Institute, USA
Adrian Di Bisceglie, Saint Louis University, USA
Geoffrey Dusheiko, University College London, UK
Jordan Feld, Toronto General Hospital, Canada
Michael Fried, University of North Carolina, USA
Robert Gish, Robert G. Gish Consultants, LLC, USA
Jason Grebely, University of New South Wales, Australia
Brent Korba, Georgetown University, USA
Shyamasundaran Kottilil, Maryland University, USA
George Lau, Humanity and Health Medical Center, Hong Kong, China
Stanley Lemon, University of North Carolina, at Chapel Hill, USA
Miriam Levy, University of Western Sydney & University of New South Wales, Australia
Michael Manns, Hannover Medical School, Germany
Patrick Marcellin, Hopital Beaujon, France
Marion Peters, University of California, San Francisco, USA
Ulrike Protzer, Technical University of Munich, Germany
Harry Janssen, Erasmus Medical Center, the Netherlands
The Committees of HEP-DART consist of experts with a tremendous amount of experience and knowledge in the field of hepatology.
Plenary Lectures from
Norah Terrault
University of Southern California, USA
Ralf Bartenschalger
University of Heidelberg, Germany
Helene Strick-Marchand
Pasteur Institute, France
George Lau
Humanity and Health Medical Group, Hong Kong
Manal El-Sayed
Ain Shams University, Egypt
Stephan Urban
University of Heidelberg, Germany
Fabien Zoulim
University of Lyon, France
Geoff Dusheiko
Kings College Hospital, United Kingdom
Scientific Program
40+ World-class invited key opinion leaders
CME accreditation
5 days of scientific programming
No concurrent sessions
Academic and Industry sessions
5 Panel discussions + 1 debate
1 poster session with poster review
12+ Hours dedicated to networking
To stay up to date on the latest speakers please sign-up for our mailing list
HEP DART 2023: Registration
Hep-DART 2023 to be held December 3rd-7th, 2023 at the Hacienda del Mar (a Marriott company)
Los Cabos, Mexico
Hotel rooms available at a significantly discounted price for the conference. Available during the conference and 4 nights pre and post conference.
Rates starting at $199++
For additional information, please reach us at info@ihorizonsed.com
Fees and Deadlines
Special rate for students, post-docs, and nurses* - $1,000
Academic/Government/Non-Profit Registration - $1,200
Industry Registration - $1,700
* Resource-Limited Settings: We offer special discounts to all community representatives, NGO representatives, and healthcare professionals from resource limited settings. Please email us at info@hepdart.com for more information.
*Deadline to register in November 20th, 2023
Registration package includes
Access to all meeting sessions
Access to conference App and electronic abstract book
Official conference materials and T-shirt
Welcome reception
4 breakfasts (Monday-Thursday)
3 lunches (Monday-Wednesday)
AM and PM coffee breaks for the duration of the meeting
Poster reception
Closing dinner
Heavily discounted hotel room rates
*terms and conditions*
Important Dates
Monday, June 19, 2023:
Early registration is open
Monday, July 17, 2023:
Early registration deadline at 11:59 EST pm US Eastern Time
Monday, October 2, 2023:
Regular registration deadline at 11:59 EST pm US Eastern Time
Monday, October 2, 2023:
Abstract submission deadline at 11:59 EST pm US Eastern Time
Monday, October 2, 2023:
Scholarship application deadline at 11:59 EST pm US Eastern Time
Monday, November 20, 2023:
Late registration deadline at 11:59 pm US Eastern Time
Sunday, December 03, 2023:
HEP-DART 2023 meeting will start at 4:00 pm US Mountain Standard Time
Thursday, December 07, 2023:
HEP-DART 2023 meeting adjourns at 12:00 pm US Mountain Standard Time
Meeting Ojectives
Understand the role of viral targets in the drug development and discovery process
Identify the next generation of inhibitors of viral hepatitis (HAV, HBV, HCV, HDV, HEV), NASH and HCC
Describe the latest developments in HCV, HDV, and HBV therapeutics
Road to HBV Cure
Assess the impact of resistance and treatment failure in the drug development and discovery process
Understand the role of hepatic cells in viral pathogenesis
Understand immune status and the viral genetics of viral hepatitis
Review current treatment guidelines for HCV and HBV in adults and children
Increase awareness of the clinical impact of antiviral agents
Understand the consequences of NASH and co- infections with HIV on the management of patients
Assess the role of vaccines and therapeutic vaccines in future therapies for viral hepatitis, NASH, and co-infections with HIV
Understand the transmission of viral hepatitis
Describe novel genetic markers for HCV and HBV disease and treatment
Understand the demographic and ecologic conditions that favor the spread of viral hepatitis in various populations including prisons and people who use drugs.
Understand the obstacles to access to treatment and preventive methods
Determine the economic impact of HCV and HBV therapeutics
Provide recommendations for a global blueprint for “Seek, Test, Treat and Eradicate” efforts